BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Company News  |  Deals

Anchor Therapeutics, J&J deal

Anchor partnered with Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary to use Anchor's pepducin technology to discover and develop therapeutics targeting G protein-coupled receptors (GPCRs) for...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >